Peru Cancels Anchovy Season, Driving Fish Oil Squeeze as EU Deregulates SAMe
Peruvian anchovy catch cancellations will inflate marine lipid prices, whilst the EU's non-novel ruling on SAMe opens new longevity formulation pipelines.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 26 October 2026
Peru has cancelled its second 2026 anchovy fishing season following severe biomass depletion and climate-driven marine disruptions. The decision cuts off crude fish oil supply from the world's most critical reduction fishery. Compounding this supply contraction, Chinese buyers have aggressively expanded their intake of Peruvian fish oil, absorbing export volumes and restricting access for Western supplement producers reliant on imported marine lipids.
As omega-3 supply lines tighten, alternative active ingredients are seeing swift regulatory clearance. The European Commission has confirmed that S-adenosylmethionine (SAMe) is classified as non-novel for food supplement applications. By eliminating the multi-year dossier requirements mandated under Novel Food Regulation (EU) 2015/2283, the ruling permits brand owners across Europe to incorporate SAMe directly into joint, liver, and cognitive formulations without pre-market authorisation delays.
Large pharmaceutical and nutrition groups are already deploying capital into proactive cellular health. Nestlé Health Science has rolled out Solgar Prime, a direct-to-consumer and retail line targeting the longevity segment. The launch increases commercial pressure on independent brands, requiring contract manufacturers to offer premium differentiation as multinationals expand shelf dominance in high-street pharmacies.
What this means for the United Kingdom
UK brand owners must immediately review forward contracts for concentrated EPA and DHA softgels. Rising input costs and extended lead times from Peruvian suppliers necessitate qualified backups, including high-potency algal oils derived from Schizochytrium to protect retail price architecture. On the regulatory front, UK brands exporting into Northern Ireland or the EU single market can now formulate with SAMe immediately without novel food documentation. However, regulatory leads must verify that the UK Food Standards Agency (FSA) does not challenge the ingredient under domestic post-Brexit novel food regimes before launching domestically in Boots or Holland & Barrett.
Many leading brands in this category are manufactured in partnership with Supplement Factory.